DE69834271D1 - Steroid-3-o-sulfamat-derivate als estronsulfatase-hemmer - Google Patents

Steroid-3-o-sulfamat-derivate als estronsulfatase-hemmer

Info

Publication number
DE69834271D1
DE69834271D1 DE69834271T DE69834271T DE69834271D1 DE 69834271 D1 DE69834271 D1 DE 69834271D1 DE 69834271 T DE69834271 T DE 69834271T DE 69834271 T DE69834271 T DE 69834271T DE 69834271 D1 DE69834271 D1 DE 69834271D1
Authority
DE
Germany
Prior art keywords
estronsulfatase
steroid
inhibitors
sulfamate derivatives
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69834271T
Other languages
English (en)
Other versions
DE69834271T2 (de
Inventor
John Reed
Victor Potter
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sterix Ltd
Original Assignee
Sterix Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sterix Ltd filed Critical Sterix Ltd
Publication of DE69834271D1 publication Critical patent/DE69834271D1/de
Application granted granted Critical
Publication of DE69834271T2 publication Critical patent/DE69834271T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J73/00—Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms
    • C07J73/001—Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms by one hetero atom
    • C07J73/003—Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms by one hetero atom by oxygen as hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/366—Lactones having six-membered rings, e.g. delta-lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0005—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring the nitrogen atom being directly linked to the cyclopenta(a)hydro phenanthrene skeleton
    • C07J41/0016—Oximes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J73/00—Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J73/00—Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms
    • C07J73/001—Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms by one hetero atom
    • C07J73/005—Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms by one hetero atom by nitrogen as hetero atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J75/00—Processes for the preparation of steroids in general
DE69834271T 1997-12-04 1998-12-03 Steroid-3-o-sulfamat-derivate als estronsulfatase-hemmer Expired - Lifetime DE69834271T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB9725750A GB2331988B (en) 1997-12-04 1997-12-04 Polycyclic sulphamate inhibitors or oestrone sulphatase
GB9725750 1997-12-04
PCT/GB1998/003616 WO1999027935A1 (en) 1997-12-04 1998-12-03 Steroid 3-o-sulphamate derivatives as inhibitors of oestrone sulphatase

Publications (2)

Publication Number Publication Date
DE69834271D1 true DE69834271D1 (de) 2006-05-24
DE69834271T2 DE69834271T2 (de) 2006-10-19

Family

ID=10823156

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69834271T Expired - Lifetime DE69834271T2 (de) 1997-12-04 1998-12-03 Steroid-3-o-sulfamat-derivate als estronsulfatase-hemmer

Country Status (10)

Country Link
US (2) US6949561B1 (de)
EP (1) EP1051177B1 (de)
JP (1) JP3820349B2 (de)
AT (1) ATE323495T1 (de)
AU (1) AU1345699A (de)
DE (1) DE69834271T2 (de)
DK (1) DK1051177T3 (de)
ES (1) ES2260856T3 (de)
GB (2) GB2331988B (de)
WO (1) WO1999027935A1 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040127473A1 (en) * 1996-12-05 2004-07-01 Reed Michael John Compound
ATE401896T1 (de) 1998-06-10 2008-08-15 Sterix Ltd Pharmazeutische zusammensetzungen mit tumor nekrose faktor und 2-methoxyestron-3-o-sulphamat als estrone sulphatasehemmern
US6667299B1 (en) 2000-03-16 2003-12-23 Hollis-Eden Pharmaceuticals, Inc. Pharmaceutical compositions and treatment methods
US20080015174A1 (en) * 1998-11-24 2008-01-17 Reading Christopher L Metabolic Disease Treatments
US7078395B1 (en) 1999-06-16 2006-07-18 Sterix Limited Methods for treating or preventing cancer by preventing, inhibiting or arresting cell cycling
NZ515061A (en) * 1999-04-30 2004-04-30 Sterix Ltd Use of a cyclic compound in cell cycling
GB9913536D0 (en) * 1999-06-10 1999-08-11 Sterix Ltd Use
CO5261573A1 (es) * 1999-11-19 2003-03-31 Novartis Ag Derivados de benzoxa y bezotiazol, compuesto y composicion farmaceutica que los contiene y proceso para la preparacion de la mencionada composicion
US7335650B2 (en) 2000-01-14 2008-02-26 Sterix Limited Composition
JPWO2001081364A1 (ja) 2000-04-24 2004-01-08 協和醗酵工業株式会社 エストラ−１，３，５（１０）−トリエン誘導体
DE10307103A1 (de) 2003-02-19 2004-09-09 Schering Ag Antitumor wirksame 2-substituierte D-Homostra-1,3,5(10)-trien-3-yl sulfamate
US7910755B2 (en) * 2004-09-29 2011-03-22 Harbor Biosciences, Inc. Stem cell expansion and uses
US10030478B2 (en) 2014-05-20 2018-07-24 Baker Hughes, A Ge Company, Llc Mechanically actuated variable choke system for subterranean use
CN104311621B (zh) * 2014-11-18 2016-05-11 郑州大学 D环修饰的甾体β-内酰胺类化合物、其制备方法及其应用
WO2016084790A1 (ja) * 2014-11-25 2016-06-02 第一三共株式会社 ヒドロナフトキノリン誘導体

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2324592A1 (de) * 1973-05-16 1974-12-05 Basf Ag Substituierte benzofuranylester
DE2402370A1 (de) * 1974-01-18 1975-07-31 Basf Ag Substituierte benzofuranylester
US4155918A (en) 1976-10-28 1979-05-22 Hoffmann-La Roche Inc. Novel D-homosteroids
HU175287B (hu) * 1977-08-18 1980-06-28 Richter Gedeon Vegyeszet Sposob poluchenija novykh proizvodnykh 3-amino-17al'fa-aza-d-gomo-androstana,dalee ikh kislotoaddicionnykh i chetvjortichnykh solej
DE2755578A1 (de) 1977-12-09 1979-06-13 Schering Ag C-homo-oestratriene
DE3243158A1 (de) * 1982-11-23 1984-05-24 Basf Ag, 6700 Ludwigshafen Neue sulfonsaeureester von hydroxycumarinen, ihre herstellung und sie enthaltende arzneimittel
JPS61502186A (ja) 1984-05-21 1986-10-02 エス・ア−ル・アイ・インタ−ナシヨナル １７αβ−ヒドロキシ−７α−メチル−Ｄ−ホモ−１９−ノルアンドロスト−４，１６−ジエン−３−オンおよびその１７−エステル、ならびにその製法および使用
US4874891A (en) 1986-05-01 1989-10-17 Washington University Open "D" ring hormone analogs
PT94305B (pt) * 1989-06-12 1997-02-28 Robins Co Inc A H Processo para a preparacao de compostos tendo um ou mais radicais aminossulfoniloxi uteis como produtos farmaceuticos
US6011024A (en) 1991-08-28 2000-01-04 Imperial College Of Science Technology & Medicine Steroid sulphatase inhibitors
GB9625334D0 (en) * 1996-12-05 1997-01-22 Imperial College Compound
GB9118478D0 (en) 1991-08-29 1991-10-16 Imperial College Steroid sulphatase inhibitors
GB9603325D0 (en) * 1996-02-16 1996-04-17 Imperial College A compound
GB9118465D0 (en) 1991-08-29 1991-10-16 Imperial College Steroid sulphatase inhibitors
JP2746041B2 (ja) 1992-02-14 1998-04-28 三菱化学株式会社 新規なステロイド誘導体
US5260299A (en) 1992-03-05 1993-11-09 American Home Products Corporation Rapamycin 42-sulfonates and 42-(N-Carboalkoxy)Sulfamates Useful as Immunosuppressive Agents
PL175347B1 (pl) 1992-04-03 1998-12-31 Upjohn Co Trójpierścieniowe heterocykliczne aminy aktywne farmaceutycznie
WO1997005126A1 (en) 1995-07-29 1997-02-13 Smithkline Beecham Plc Mupirocinsulfamates with antibacterial activity
JP2000506161A (ja) * 1996-03-05 2000-05-23 インペリアル カレッジ オブ サイエンス テクノロジー アンド メディシン スルファメート基を有する化合物
KR20000035979A (ko) * 1996-09-12 2000-06-26 야마구찌 다까시 3-치환-ｄ-호모-1,3,5(10)-에스트라트리엔 유도체
DE19712488A1 (de) 1997-03-25 1998-10-01 Knoell Hans Forschung Ev Steroidsulfamate, Verfahren zu ihrer Herstellung und Anwendung derselben
US6248780B1 (en) 1998-10-01 2001-06-19 Duquesne University Of The Holy Ghost Compounds for the treatment of estrogen-dependent illnesses and methods for making and using the same

Also Published As

Publication number Publication date
JP3820349B2 (ja) 2006-09-13
GB2331988A (en) 1999-06-09
US20050124643A1 (en) 2005-06-09
EP1051177A1 (de) 2000-11-15
GB0227655D0 (en) 2003-01-08
GB2331988A9 (en)
ATE323495T1 (de) 2006-05-15
GB2380939A (en) 2003-04-23
EP1051177B1 (de) 2006-04-19
AU1345699A (en) 1999-06-16
ES2260856T3 (es) 2006-11-01
US6949561B1 (en) 2005-09-27
WO1999027935A1 (en) 1999-06-10
DK1051177T3 (da) 2006-07-24
DE69834271T2 (de) 2006-10-19
GB2331988B (en) 2003-04-16
GB2380939B (en) 2003-09-10
GB9725750D0 (en) 1998-02-04
JP2001524524A (ja) 2001-12-04

Similar Documents

Publication Publication Date Title
ES2085876T3 (es) Derivado de bifenilmetano, su utilizacion y composiciones farmacologicas que contienen el mismo.
CY2559B1 (en) Non-steroidal polycyclic ring su lphamate derivatives, their preparation and their use as oestrone sulphatase inhibitors
DE69834271D1 (de) Steroid-3-o-sulfamat-derivate als estronsulfatase-hemmer
TR199902626T2 (xx) Enflamasyon tedavisi i�in ikameli benzopiran t�revleri.
DE69325454D1 (de) Taxol-derivate
PT1413582E (pt) Pirrolobenzodiazepinas dimericas
ES2083595T3 (es) Derivados de indol que inhiben la biosintesis de leucotrienos.
YU11997A (sh) Laktamski derivati i njihove farmaceutske kompozicije
BR9711586A (pt) Compostos e uso dos mesmo
DE69739051D1 (de) Östrogen-Sulfamate als Sulfataseinhibitoren
DE69841374D1 (de) 3-o-sulfamatsteroidderivate als hemmer von estronsulfatase
ES2174298T3 (es) Derivados de aminotiazol, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
ES2179864T3 (es) 4-benzoil-isoxazoles y su uso como herbicidas.
ATE320422T1 (de) Metalloproteinase inhibitoren
TR199701298T1 (xx) Tetralinler.
UY24915A1 (es) Derivados de benzoxazindiona, aplicación de los mismos y medicamentos que los contienen
DE60003697D1 (de) Aktive marine alkaloiden
TR199701011A2 (xx) 1-karba-(detia)-sefalosforin t�revleri.
ES2099621T3 (es) Procedimiento para producir un derivado de imidazol.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition